Budget impact analysis of the 21-gene assay (Oncotype DX® breast cancer) for the breast cancer treatment in the Basque country

Autor: M. Hidalgo, Javier Mar, A. Paisan, M.G. Toribio, E. Galve, P. Purificación Martínez del Prado, I. Perez, Isabel Alvarez, Juan Fernando Arango, Patricia Novas, L. Larburu, S. Dominguez, N. Ancizar, Arrate Plazaola, C. Churruca, Oliver Ibarrondo, Ainhara Lahuerta, G. Unanue

Publikováno v: Annals of Oncology. 27:vi54

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3d1f9cb33f3e73c531595661ec04f5fd
https://doi.org/10.1093/annonc/mdw364.37

First-line docetaxel (Dx) and capecitabine (Cap) in advanced head and neck cancer

Autor: Aintzane Sancho, N. Fuente, R. Fernández, Itziar Rubio, A. Gil-Negrete, A. Martinez-Bueno, A. Ruiz de Lobera, Guillermo Lopez-Vivanco, N. Ancizar, J. M. Mañé

Publikováno v: Journal of Clinical Oncology. 25:16505-16505

16505 Background: Dx and Cap are useful drugs in head and neck cancer. Our purpose was to establish the efficacy and safety of this combination in non selected patients (pts) with advanced or metastatic (M1) head and neck cancer. Methods: : Between A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9e4a3ae811c6ef255ff8bf2cb315c864
https://doi.org/10.1200/jco.2007.25.18_suppl.16505

Increased expression levels of human telomerase reverse transcriptase (hTERT) mRNA correlates with poor prognosis in resected non-small cell lung cancer (NSCLC) patients

Autor: A. Muñoz, Unai Aresti, Guillermo Lopez-Vivanco, N. Ancizar, Begoña Calvo, Sergio Carrera, A. Martinez-Bueno, J. Ferreiro, M. S. Jangi, Itziar Rubio

Publikováno v: Journal of Clinical Oncology. 25:10594-10594

10594 Background: Telomerase adds hexameric TTAGGG nucleotide repeats onto the ends of chromosomal DNAs to compensate for losses of each cell replication. In several tumors, telomerase is expressed in a way that tumoral cell proliferates indefinitely

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4b9453205b67e52bf492d4a71bf05d62
https://doi.org/10.1200/jco.2007.25.18_suppl.10594

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases.

Autor: Goicoechea I; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, 20014, Spain., Rezola R; Department of Pathology and Anatomy, Onkologikoa- Instituto Oncológico, San Sebastián, 20014, Spain., Arestin M; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, 20014, Spain., M Caffarel M; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, 20014, Spain.; IKERBASQUE, Basque Foundation for Science, Bilbao, 48013, Spain., Cortazar AR; CIC bioGUNE, Derio, 48160, Spain., Manterola L; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, 20014, Spain., Fernandez-Mercado M; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, 20014, Spain., Armesto M; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, 20014, Spain., Sole C; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, 20014, Spain., Larrea E; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, 20014, Spain., M Araujo A; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, 20014, Spain., Ancizar N; Oncology Department, University Hospital Donostia, San Sebastián, 20014, Spain., Plazaola A; Onkologikoa- Instituto Oncológico, San Sebastián, 20014, Spain., Urruticoechea A; Onkologikoa- Instituto Oncológico, San Sebastián, 20014, Spain., Carracedo A; IKERBASQUE, Basque Foundation for Science, Bilbao, 48013, Spain.; CIC bioGUNE, Derio, 48160, Spain.; Department of Biochemistry and Molecular Biology, University of the Basque Country, Leioa , 48940, Spain., Ruiz I; Department of Pathology and Anatomy, University Hospital Donostia, San Sebastián, 20014, Spain., Alvarez Lopez I; Oncology Department, University Hospital Donostia, San Sebastián, 20014, Spain., H Lawrie C; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, 20014, Spain.; IKERBASQUE, Basque Foundation for Science, Bilbao, 48013, Spain.; Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DU, UK.

Publikováno v: F1000Research [F1000Res] 2017 Aug 30; Vol. 6, pp. 1606. Date of Electronic Publication: 2017 Aug 30 (Print Publication: 2017).